Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

This study has been terminated.
(Poor enrollment)
Sponsor:
Collaborators:
Abbott
Pfizer
Information provided by (Responsible Party):
Stephanie Brictson, Temple University
ClinicalTrials.gov Identifier:
NCT01068873
First received: February 12, 2010
Last updated: June 5, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)